Arcutis Biotherapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
November 11 2020 - 04:05PM
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage
biopharmaceutical company focused on developing and commercializing
treatments for unmet needs in immune-mediated dermatological
diseases and conditions, or immuno-dermatology, today announced
that Frank Watanabe, President and CEO, will present a corporate
overview during the Stifel 2020 Virtual Healthcare Conference
taking place November 16-18, 2020.
Details for the presentation are as
follows: Stifel
2020 Virtual Healthcare
Conference Presentation
Date: Wednesday, November 18, 2020
Presentation Time: 12:20 p.m. PST / 3:20
p.m. EST
The presentation will be webcast and may be
accessed at the “Events & Presentations” section of the
Company’s website at
https://investors.arcutis.com/events-and-presentations. Arcutis
will maintain an archived replay of the webcast on its website for
30 days after the conference.
About Arcutis
- Bioscience, applied to the skin.Arcutis
Biotherapeutics, Inc. (Nasdaq: ARQT) is a late-stage
biopharmaceutical company focused on developing and commercializing
treatments for unmet needs in immune-mediated dermatological
diseases and conditions, or immuno-dermatology. The company is
leveraging recent advances in immunology and inflammation to
develop differentiated therapies against biologically validated
targets to solve persistent treatment challenges in serious
diseases of the skin. Arcutis’ robust pipeline includes four novel
drug candidates currently in development for a range of
inflammatory dermatological conditions. The company’s lead product
candidate, topical roflumilast, has the potential to revitalize the
standard of care for plaque psoriasis, atopic dermatitis, scalp
psoriasis, and seborrheic dermatitis. For more information, visit
www.arcutis.com or follow the company on LinkedIn and Twitter.
Investor
Contact:Heather Rowe
ArmstrongVice President, Investor Relations & Corporate
Communicationsharmstrong@arcutis.com805-418-5006, Ext. 740
Arcutis Biotherapeutics (NASDAQ:ARQT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Arcutis Biotherapeutics (NASDAQ:ARQT)
Historical Stock Chart
From Mar 2023 to Mar 2024